Information  X 
Enter a valid email address

Valirx PLC Ord 0.1P (VAL)

Date Time Source Announcement
23 Jul 2019 4:02 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Appointment of Joint Broker
10 Jul 2019 7:00 am
RNS
Marketing and Communications Update
09 Jul 2019 11:14 am
RNS
Change of Registered Address
04 Jul 2019 7:00 am
RNS
Update re VAL301
28 Jun 2019 1:33 pm
RNS
Holding(s) in Company
  12:31 pm
RNS
Issue of Equity
  12:03 pm
RNS
Result of AGM
26 Jun 2019 12:00 pm
RNS
Holding(s) in Company
  7:00 am
RNS
US Notice of Allowance-VAL201 & Metastatic Cancer
25 Jun 2019 2:50 pm
RNS
Further re: Termination of Subscription Agreement
24 Jun 2019 12:45 pm
RNS
Holding(s) in Company
21 Jun 2019 12:00 pm
RNS
Holding(s) in Company
20 Jun 2019 7:00 am
RNS
Update on VAL201 Clinical Trial
19 Jun 2019 12:00 pm
RNS
Holding(s) in Company
13 Jun 2019 7:00 am
RNS
Placing, Subscription Agreement & Issue of Warrant
10 Jun 2019 7:00 am
RNS
Subscription Agreement Update
05 Jun 2019 7:00 am
RNS
Notice of AGM & Update of Subscription Agreement
31 May 2019 11:07 am
RNS
Subscription Agreement Update
  10:42 am
RNS
Holding(s) in Company
30 May 2019 10:30 am
RNS
Holding(s) in Company
29 May 2019 11:44 am
RNS
Holding(s) in Company
  7:00 am
RNS
Final Results
28 May 2019 7:00 am
RNS
Subscription Agreement Update
23 May 2019 12:02 pm
RNS
Holding(s) in Company
22 May 2019 7:00 am
RNS
Subscription Agreement Update
13 May 2019 2:00 pm
RNS
Price Monitoring Extension
02 May 2019 7:00 am
RNS
Acquisition of Intellectual Property& JV Agreement
29 Apr 2019 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
  11:07 am
RNS
Second Price Monitoring Extn
  11:01 am
RNS
Price Monitoring Extension
  10:55 am
RNS
Holding(s) in Company
26 Apr 2019 7:00 am
RNS
Subscription, Convertible Funds and Warrant Issue
15 Apr 2019 7:15 am
EQS
Valirx (VAL): VAL401 is going forward
26 Mar 2019 7:00 am
RNS
ValiSeek Update
21 Mar 2019 7:00 am
RNS
Update on VAL201 & VAL301 Development Progress
21 Feb 2019 11:22 am
RNS
Placing, Issue of Equity and Warrant
31 Jan 2019 7:00 am
RNS
New patent grant allowances for VAL301
11 Jan 2019 7:00 am
RNS
Publication of VAL401 peer-reviewed article
09 Jan 2019 10:41 am
RNS
ValiRx endorses the Government's new NHS strategy
03 Jan 2019 7:00 am
RNS
Holding(s) in Company
18 Dec 2018 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  11:25 am
RNS
Issue of Equity / PDMR Shareholdings
  7:00 am
RNS
Update on VAL401 - Peer-review Acceptance
10 Dec 2018 7:00 am
RNS
Update on VAL201 Clinical Trial
05 Nov 2018 7:00 am
RNS
Re scientific and investor meetings
01 Nov 2018 7:15 am
EQS
ValiRx (VAL): VAL401 Phase II trial completed
24 Oct 2018 7:00 am
RNS
Align Research Initiates Coverage
17 Oct 2018 7:00 am
RNS
VAL201 in concluding stages of Phase I/II trial
15 Oct 2018 12:00 pm
RNS
VAL401 results shortly to be on ClinicalTrials.gov
25 Sep 2018 7:00 am
RNS
Half-year Report
14 Sep 2018 12:42 pm
RNS
Issue of Equity
06 Sep 2018 7:00 am
RNS
Update on Clinical Development
24 Jul 2018 12:17 pm
RNS
Result of General Meeting
17 Jul 2018 7:00 am
RNS
US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301
06 Jul 2018 4:42 pm
RNS
Notice of GM
14 Jun 2018 7:00 am
RNS
VAL401 Update
24 May 2018 9:00 am
RNS
Price Monitoring Extension
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t